SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

$ZSTK

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

COPIED JUL 21

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

FGENBuy

Fibrogen Inc

Thane Wettig · CEO

$34K+17.0%Nov 17
FGENBuy

Fibrogen Inc

James A Schoeneck · Director

$119K+146.0%Jul 2
FGENBuy

Fibrogen Inc

Thane Wettig · CEO

$51K+36.0%Mar 25
FGENBuy

Fibrogen Inc

James A Schoeneck · Director

$105K+293.0%Mar 24
FGENBuy

Fibrogen Inc

Deyaa Adib · Chief Medical Officer

$26K+37.0%Jun 13
FGENSell

Fibrogen Inc

Thane Wettig · Chief Commercial Officer

$30K−2.0%Jun 22
FGENSell

Fibrogen Inc

Christine Chung · SVP, China Operations

$215K−5.0%Jun 15
FGENSell

Fibrogen Inc

Jeffrey L Edwards · Director

$136K−19.0%Jun 9
FGENSell

Fibrogen Inc

Jeffrey William Henderson · Director

$122K−17.0%Jun 9
FGENSell

Fibrogen Inc

Benjamin Cravatt · Director

$68K−12.0%Jun 9
FGENSell

Fibrogen Inc

Aoife Brennan · Director

$81K−14.0%Jun 9
FGENSell

Fibrogen Inc

Suzanne Blaug · Director

$147K−22.0%Jun 9
FGENSell

Fibrogen Inc

Maykin Ho · Director

$149K−21.0%Jun 9
FGENSell

Fibrogen Inc

James A Schoeneck · Director

$128K−6.0%Jun 9
FGENSell

Fibrogen Inc

Juan Graham · CFO

$30K−2.0%Jun 9
FGENSell

Fibrogen Inc

Christine Chung · SVP, China Operations

$62K−1.0%Jun 9
FGENSell

Fibrogen Inc

Mark Eisner · EVP and Chief Medical Officer

$35K−1.0%Jun 9
FGENSell

Fibrogen Inc

Enrique A Conterno · CEO

$152K−2.0%Jun 9
FGENSell

Fibrogen Inc

Enrique A Conterno · CEO

$36KApr 11
FGENSell

Fibrogen Inc

Mark Eisner · Chief Medical Officer

$172K−5.0%Apr 6
FGENSell

Fibrogen Inc

Christine Chung · SVP, China Operations

$124K−3.0%Apr 6
FGENSell

Fibrogen Inc

Enrique A Conterno · CEO

$394K−5.0%Mar 23
FGENSell

Fibrogen Inc

Christine Chung · SVP, China Operations

$330K−6.0%Mar 10
FGENSell

Fibrogen Inc

Enrique A Conterno · CEO

$1.2M−12.0%Mar 10
FGENSell

Fibrogen Inc

Mark Eisner · Chief Medical Officer

$361K−9.0%Mar 10
FGENSell

Fibrogen Inc

Juan Graham · CFO

$157K−10.0%Mar 10
FGENSell

Fibrogen Inc

Thane Wettig · Chief Commercial Officer

$287K−11.0%Mar 10
FGENSell

Fibrogen Inc

Mark Eisner · Chief Medical Officer

$26K−1.0%Mar 6
FGENSell

Fibrogen Inc

Enrique A Conterno · CEO

$31KJan 10
FGENSell

Fibrogen Inc

Christine Chung · SVP, China Operations

$41K−1.0%Jan 4
FGENSell

Fibrogen Inc

Juan Graham · CFO

$85K−10.0%Dec 15
FGENSell

Fibrogen Inc

Juan Graham · CFO

$32K−4.0%Dec 15
FGENSell

Fibrogen Inc

Enrique A Conterno · CEO

$40K−1.0%Dec 9
FGENSell

Fibrogen Inc

Thomas F Kearns Jr · Director

$152K−5.0%Sep 17
FGENBuy

Fibrogen Inc

Thane Wettig · Chief Commercial Officer

$36K+7.0%Aug 30
FGENSell

Fibrogen Inc

Pat Cotroneo · SVP, Finance, CFO

$104K−1.0%Jun 17
FGENSell

Fibrogen Inc

Thomas F Kearns Jr · Director

$630K−7.0%Mar 15
FGENSell

Fibrogen Inc

Kalevi Kurkijarvi · Director

$314K−15.0%Feb 19
FGENSell

Fibrogen Inc

Kalevi Kurkijarvi · Director

$260K−15.0%Jan 21
FGENSell

Fibrogen Inc

Kalevi Kurkijarvi · Director

$240K−15.0%Jan 15
FGENSell

Fibrogen Inc

Kalevi Kurkijarvi · Director

$242K−15.0%Dec 30
FGENSell

Fibrogen Inc

K Peony Yu · Chief Medical Officer

$139K−2.0%Dec 17
FGENSell

Fibrogen Inc

Pat Cotroneo · SVP, Finance, CFO

$134K−1.0%Dec 17
FGENSell

Fibrogen Inc

K Peony Yu · Chief Medical Officer

$147K−2.0%Sep 18
FGENSell

Fibrogen Inc

Pat Cotroneo · SVP, Finance, CFO

$134K−1.0%Sep 17
FGENSell

Fibrogen Inc

K Peony Yu · Chief Medical Officer

$509K−5.0%Sep 4
FGENSell

Fibrogen Inc

Pat Cotroneo · SVP, Finance, CFO

$764K−5.0%Sep 4
FGENSell

Fibrogen Inc

Pat Cotroneo · SVP, Finance, CFO

$1.1M−7.0%Aug 11
FGENSell

Fibrogen Inc

K Peony Yu · Chief Medical Officer

$142K−2.0%Jul 28
FGENSell

Fibrogen Inc

Pat Cotroneo · SVP, Finance, CFO

$156K−1.0%Jun 18

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.